ClinVar Miner

Submissions for variant NM_000249.3(MLH1):c.(?_-198)_1558+?del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000075048 SCV000106047 pathogenic Lynch syndrome 2013-09-05 reviewed by expert panel research Large deletion
Invitae RCV000468214 SCV000563814 pathogenic Lynch syndrome 2016-11-28 criteria provided, single submitter clinical testing This variant is a gross deletion of the genomic region encompassing the promoter and exons 1-13 of the MLH1 gene, which includes the initiator codon. It is expected to disrupt mRNA transcription and abrogate the initiation of protein translation of MLH1. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 13 of the MLH1 gene. Exon-level deletions and loss-of-function variants in MLH1 are known to be pathogenic. Deletions encompassing exons 1-13 have been observed in individuals affected with Lynch syndrome (PMID: 12658575, 16143124). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.